Albemarle (ALB) Earns Daily News Impact Score of 0.16

News headlines about Albemarle (NYSE:ALB) have been trending somewhat positive this week, according to Alpha One. The research firm, a unit of Accern, identifies positive and negative news coverage by analyzing more than 20 million blog and news sources in real-time. Alpha One ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Albemarle earned a daily sentiment score of 0.16 on Alpha One’s scale. Alpha One also gave media stories about the specialty chemicals company an impact score of 15 out of 100, indicating that recent news coverage is very unlikely to have an impact on the stock’s share price in the near term.

These are some of the news articles that may have impacted Alpha One Sentiment Analysis’s scoring:

Shares of Albemarle (NYSE:ALB) opened at 110.32 on Friday. The stock has a 50 day moving average of $107.68 and a 200 day moving average of $96.36. Albemarle has a 52 week low of $74.35 and a 52 week high of $112.88. The firm has a market cap of $12.22 billion, a P/E ratio of 26.81 and a beta of 1.41.

Albemarle (NYSE:ALB) last issued its earnings results on Wednesday, May 3rd. The specialty chemicals company reported $1.05 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.10. The firm had revenue of $722.06 million for the quarter, compared to analyst estimates of $678.74 million. Albemarle had a return on equity of 14.38% and a net margin of 6.92%. Equities analysts forecast that Albemarle will post $4.36 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, July 3rd. Shareholders of record on Thursday, June 15th will be paid a $0.32 dividend. The ex-dividend date is Tuesday, June 13th. This represents a $1.28 annualized dividend and a dividend yield of 1.16%. Albemarle’s payout ratio is presently 63.54%.

Several research firms have recently weighed in on ALB. Nomura restated a “buy” rating and set a $124.00 price objective on shares of Albemarle in a research report on Monday, May 15th. Royal Bank of Canada raised their target price on shares of Albemarle from $132.00 to $136.00 and gave the stock an “outperform” rating in a report on Monday, May 15th. Robert W. Baird reissued an “outperform” rating and issued a $125.00 price target on shares of Albemarle in a research report on Sunday, April 9th. Zacks Investment Research raised shares of Albemarle from a “hold” rating to a “buy” rating and set a $118.00 price target for the company in a research report on Tuesday, April 4th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a $120.00 price objective on shares of Albemarle in a research report on Tuesday, April 4th. Three equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $117.20.

TRADEMARK VIOLATION WARNING: “Albemarle (ALB) Earns Daily News Impact Score of 0.16” was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://sportsperspectives.com/2017/05/20/albemarle-alb-receiving-somewhat-favorable-press-coverage-analysis-finds-updated-updated.html.

About Albemarle

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

12 Month Chart for NYSE:ALB

Receive News & Ratings for Albemarle Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply